Alogliptin (SYR-322) - R & D Biopharmaceutical & Pharmaceutical Product Profile
alogliptin (SYR-322) is a late-stage R & D therapeutic product.
Sources of Information:
Research data published in this product profile are obtained primarily from companies involved in its development. In addition, the analyst used other available sources of information, including database of the US National Institutes of Health (NIH).
Rarely, and only when necessary, information was based on published scientific articles.
